3-MMC or 3-methylmethicatinone is a molecule of the class of substituted cathinones. Cathinones are a subcategory of amphetamines that share the basic amphetamine structure of a phenyl ring linked to an amino group (NH2) via an ethyl chain and an additional methyl substitution at R±.
3-MMC and other cathinones differ in their ketone substitution at the beta carbon of the amphetamine backbone, meaning that they are ²-keto-amphetamine. You can also get information about 3 mmc tablets via the web.
Image Source: Google
3-MMC has two methyl substitutions on its cathinone backbone, one on the R3 of the phenyl ring and the other on the nitrogen group of the RN. 3-MMC is an analogue of mephedrone; it is identical in structure except for the placement of the methyl group on R3 instead of R4.
In the absence of research into the substance, all discussion of the pharmacology of this substance is pure speculation due to its structure and subjective effects similar to those of other stimulants such as mephedrone, amphetamines, and 2-FMA.
3-MMC most likely acts as a dopamine and norepinephrine-releasing agent at the same time. This means that it can effectively increase levels of the neurotransmitters norepinephrine and dopamine in the brain by binding to and partially blocking the transport proteins that normally remove these monoamines from the synaptic cleft.
This allows dopamine and norepinephrine to build up in the brain, leading to a stimulating and euphoric effect.
In most countries of the world, this "research chemical" is banned together with 4-MMC (mephedrone) because it is a structural isomer.
Compared to other newer psychoactive substances, 3-MMC has had a lot of animal studies, so it is much more sophisticated than other designer drugs, despite appearing on the RC market during this decade.